Skip to Content

'
Mimi I. Hu, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Bone Healthcare Program, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Clinical Assistant Professor, Department of Internal Medicine, Texas A&M Health Science Center College of Medicine, Houston, TX

Bio Statement

Dr. Mimi I. Hu graduated from Rice University with a degree in mechanical engineering and obtained her medical degree from the University of Texas - Houston Health Sciences Center. She completed her residency and endocrine fellowship at the Baylor College of Medicine, where she also served as chief medical resident. After completion of her research fellowship at M. D. Anderson, she joined the faculty in 2007 as an assistant professor in the department of endocrine neoplasia and hormonal disorders. Dr. Hu’s clinical expertise is in the evaluation and treatment of patients with thyroid carcinoma, hereditary endocrine neoplasia disorders and metabolic bone and mineral disorders. She is a collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid carcinoma. She has published articles and book chapters evaluating the management of medullary thyroid carcinoma, multiple endocrine neoplasia, bone health in cancer patients, endocrine complications of head and neck surgery, and paraneoplastic endocrine disorders.

Research Interests

Novel therapeutics for thyroid cancer
Medullary thyroid cancer
Bone and mineral metabolism disorders

Clinical Interests

Thyroid cancer
Multiple endocrine neoplasia, Types 1 and 2
Bone and mineral metabolism disorders
Parathyroid disorders
Pituitary tumors
Endocrine sequelae of cancer and its therapies

Education & Training

Degree-Granting Education

2000 University of Texas Houston Health Science Center, Houston, TX, MD, Medicine
1993 Rice University, Houston, TX, BS, Mechanical Engineering

Postgraduate Training

8/2005-7/2010 Clinical Research, Curriculum, Center for Clinical Research and Evidence-Based Medicine, University of Texas-Houston Medical School, Houston, TX, Kathleen Kennedy, MD
7/2004-6/2007 Clinical Fellowship, Endocrinology, Baylor College of Medicine, Houston, TX, Ashok Balasubramanyam
7/2001-6/2003 Clinical Residency, Internal Medicine, Baylor College of Medicine, Houston, TX, Amir Halevy
6/2000-6/2001 Clinical Internship, Internal Medicine, Baylor College of Medicine, Houston, TX, Amir Halevy

Board Certifications

2006 Endocrinology, Diabetes and Metabolism
2004 Internal Medicine

Experience/Service

Academic Appointments

Chief Medical Resident, Division of Internal Medicine, Baylor College of Medicine, Houston, TX, 7/2003-6/2004

Administrative Appointments/Responsibilities

Member-Multidisciplinary Bone Health Center Steering Committee, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, 7/2009-present
Member-Department Newsletter/Website Committee, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2/2009-present
Member-Endocrine Center Steering Committee for the Institute of Personalized Cancer Therapy, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 10/2008-present
Fellowship Program Director, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2008-present
Member-Thyroid Cancer Survivorship Program, Department of Endocrine Neoplasia and Hormonal Disorders, Thyroid Cancer Survivorship Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008-present

Institutional Committee Activities

Member, Pharmacy & Therapeutics Committee, 2/2011-present

Honors and Awards

2011 ENDO 2011 Outstanding Abstract Award and Presidential Poster Competition Finalist, Encocrine Society 93rd Annual Meeting
2011 U.S. News Top Doctors, U.S. News and World Report
2006 Travel Grant Award for Young Investigators, American Thyroid Association 77th Annual Meeting
1999 Alpha Omega Alpha Honor Society

Professional Memberships

American Association of Clinical Endocrinologists
Member, 2005-present
American College of Physicians
Member, 2000-present
American Medical Association
Member, 1996-present
American Society for Bone and Mineral Research
Member, 2007-present
American Society of Clinical Oncology
Member, 2007-2010
American Thyroid Association
Member, 2006-present
ASBMR Women in Bone and Mineral Research Committee
Council Member, 2008-2011
Endocrine Society
Member, 2006-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid 21(2):189-92, 2/2011. e-Pub 12/2010. PMCID: PMC3025175.
2. Khan MI, Waguespack SG, Hu MI. Medical Management of Postsurgical Hypoparathyroidism. Endocr Pract. e-Pub 12/2010. PMID: 21134871.
3. Stava CJ, Jimenez C, Hu MI, Vassilopoulou-Sellin R. Skeletal sequelae of cancer and cancer treatment. J Cancer Surviv 3(2):75-88, 6/2009. e-Pub 5/2009. PMID: 19412668.
4. Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB. Recent advances in thyroid cancer. Curr Probl Surg 45(3):156-250, 3/2008. PMID: 18346477.
5. Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23(6):826-36, 2008. PMCID: PMC2677083.

Invited Articles
1. Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. Ann N Y Acad Sci 1218(1):47-54, 2/2011. e-Pub 9/2010. PMID: 20946574.
2. Hu MI, Lu H, Gagel RF. Cancer Therapies and Bone Health. Curr Rheumatol Rep 12(3):177-85, 6/2010. PMID: 20437119.
3. Jiménez C, Hu MI, Gagel RF. Management of medullary thyroid carcinoma. Endocrinol Metab Clin North Am 37(2):481-96, 2008. PMID: 18502338.
4. Hu MI, Cote G, Gagel RF. RET gene: a therapeutic target in medullary thyroid carcinoma. Current Problems in Surgery 45(3):156-250, 2008.
5. Hu MI, Gagel RF, Jimenez C. Bone loss in patients with breast or prostate cancer. Curr Osteoporos Rep 5(4):170-8, 2007. PMID: 18430392.
Other Articles
1. Hu MI. Multiple Endocrine Neoplasia Type 2: A Case-Based Discussion. Department of Endocrine Neoplasia and Hormonal Disorders Newsletters 3(2), 2010.
2. Hu MI. Building Bone Health in Cancer Patients. Department of Endocrine Neoplasia and Hormonal Disorders Newsletter 2(3), 2009.
3. Hu MI. Medical Management of Medullary Thyroid Carcinoma. Department of Endocrine Neoplasia and Hormonal Disorders Newsletter 1(2), 2008.
4. Hu MI, Hoff AO, Gagel RF. Short-term Teriparatide in the Treatment of Postoperative Hypocalcemia. EndoTrends 14(1):4-5, 2007.

Book Chapters
1. Alford E, Hu MI, Ahn P, Lamont JP. Thyroid and Parathyroid Cancers. In: Cancer Management: A Multidisciplinary Approach, 13th Edition. CMPMedica, 2011.
2. Hu M, Gagel RF. Multiple Endocrine Neoplasia Type 2. In: Endocrinology, 6th edition. Ed(s) JL Jameson, LJ DeGroot. Saunders, 2010.
3. Hu MI, Sherman SI. Endocrine complications of head and neck surgery. In: Complications in Head and Neck Surgery, 2nd edition. Ed(s) Eisele, DW, 2009.
4. Hu MI, Yeung SJ, Gagel RF. Endocrine paraneoplastic syndromes. In: Internal Medicine Care of Cancer Patients. Ed(s) Escalante C, Yeung J, Gagel RF. BC Decker Inc; the Holland-Frei Series: Ontario, 2009.
5. Hu MI, Vassilopoulous-Sellin R, Lustig R, Lamont J. Thyroid and Parathyroid Cancers. In: Cancer Management: A Multidisciplinary Approach, 11th Edition. CMPMedica, 2009.
6. Hu MI, Gagel RF. Calcitonin Gene Family of Peptides. In: Principles of Bone Biology, 3rd edition. Ed(s) Bilezikian J, Raisz L, Rodan G, 2008.

Last updated: 8/22/2011